The Vector Core is in a unique position to begin offering AAV services to our customers. AAV (adeno-associated virus) is another viral vector system, and one that many investigators at the University of Michigan have expressed interest in utilizing on campus.
Please tell us how you would use AAV
Help us assess interest and usage of AAV by filling out this quick, 60-second survey.
It should only take a minute of your time and the feedback we gather in this survey will determine how we are able to move forward with AAV services.
We really appreciate you taking the time to provide us with this valuable feedback.
Tom Lanigan, Ph.D.
Director, Vector Core
About the Vector Core
The Vector Core produces biological products (gene transfer vectors) that facilitate the transfer of specific genes into either normal or aberrant cells. The Vector Core also provides intellectual and technical advice to researchers regarding the optimal use of these systems. Gene transfer vectors require special handling precautions, and manufacturing systems that lend themselves to a core structure that optimizes efficiencies of scale and cost to the research community. The specific objectives of the Vector Core are to:
- Provide a Core laboratory for the construction, purification and characterization of recombinant vectors containing genes relevant to the study of disease models for use as in vitro and in vivo gene transfer reagents. These systems include both non-viral (expression plasmid) and viral (recombinant lentivirus, recombinant retrovirus, and recombinant adenovirus) technologies;
- Collaborate closely with researchers to ensure the Vector Core provides the platforms our customers require, and to institute the use of new technologies;
- Maintain qualified staff and provide high quality, cost effective products to our researchers.
To learn more, download the Vector Core Flyer.
Thomas Lanigan, Ph.D. Supervisor, Vector Core